Onkologie. 2018:12(6):278-282 | DOI: 10.36290/xon.2018.050
Anemia in oncology patients – diagnostics and therapy
- Oddělení klinické hematologie FN Brno
- Lékařská fakulta Masarykovy univerzity Brno
Anemia is a common complication in patients with cancer, its incidence increases in patients receiving chemotherapy.The presence of anemia negatively impacts survival, worsens the quality of life of oncological patients, and in some casesmay affect the success of oncology treatment. The causes of anemia in these patients are usually multifactorial. The mostcommon causes of anemia in oncology patients are blood loss, anemia of chronic disease, chemotherapy or radiationtherapy induced bone marrow aplasia, bone marrow infiltration, autoimmune hemolytic anemia and microangiopathichaemolytic anemia. An essential prerequisite for anemia treatment is a consistent differential diagnosis aimed at determiningthe cause of anemia. Treatment of anemia involves therapy of the underlying disease, supportive treatment aserythrocyte transfusions, erythropoiesis stimulating agents, iron supplementation. Anemia treatment can improve theoutcome of cancer treatment.
Keywords: anemia, cancer, iron deficiency, anemia of chronic disease, erythropoiesis stimulating agents
Published: December 15, 2018 Show citation
References
- Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 1968; 405: 5-37.
Go to PubMed... - National Comprehesive Cancer Network. Cancer and chemotherapy-induced anémie. Version 2.2018.
- Greil R, Thödtman R, Roila F; ESMO Guidelines Working Group. Erythropoietins in cancer patients: ESMO recommendations for use. Ann Oncol. 2008; 19(Suppl 2): 113-115.
Go to original source... Go to PubMed... - Knight K, Wade S, Balducci L. Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med. 2004; 116(Suppl. 7A): 11S-26S. Go to original source... Go to PubMed...
- Ludwig H, Van Belle S, Barrett-Lee P, et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer 2004; 40(15): 2293-2306. Go to original source... Go to PubMed...
- Adamson JW. The anemia of inflammation/malignancy: mechanisms and management. Hematology Am Soc Hematol Educ Program. 2008: 159-65. Go to original source... Go to PubMed...
- Morton JM, George JN. Microangiopathic Hemolytic Anemia and Thrombocytopenia in Patients With Cancer. J Oncol Pract. 2016; 12(6): 523-530. Go to original source... Go to PubMed...
- van Eeden R, Rapoport BL. Current trends in the management of anaemia in solid tumours and haematological malignancies. Curr Opin Support Palliat Care 2016; 10(2): 189-194. Go to original source... Go to PubMed...
- Aapro M, Beguin Y, Bokemeyer C, et al; ESMO Guidelines Committee. Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines. In Ann Oncol 2018? 20.2.2018 [cit. 23-6-2018]. Dostupné z https://doi.org/10.1093/annonc/mdx758?20-2-2018. [cit. 23-6-2018]. Go to original source... Go to PubMed...
- Rizzo JD, Brouwers M, Hurley P, et al. American society of clinical oncology/american society of hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Oncol Pract. 2010; 6(6): 317-320. Go to original source... Go to PubMed...